K 2 S 2 O 8 (Potassium Persulfate)‐Mediated Heterocyclic Ring Formations
ChemistrySelect · 2025-09 · 10 (35)
DOI: 10.1002/slct.202503555 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemistrySelect, online erschienen am 15.09.2025. Verfasst von Ravi Varala und 4 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 97 Literaturangaben. Gefördert von: King Khalid University.
Abstract (Originalsprache)
A variety of oxidants that have demonstrated effective application in the oxidative transformation reactions include molecular oxygen, DDQ, p ‐benzoquinone, TBHP, PhI(OAc) 2 , I 2 , metal oxidants, oxone, persulfates, and others. Among these oxidants, which include both inorganic and organic types, potassium persulfate (K 2 S 2 O 8 ) has emerged as a cost‐effective and easily accessible inorganic oxidant suitable for the purpose. Its applications span from laboratory experiments to industrial processes. This mini‐review discusses the role of K 2 S 2 O 8 in the formation of heterocyclic rings, specifically focusing on the synthesis of diverse heterocyclic scaffolds, including simple, fused, and spirocyclic heterocycles. In addition to the advantages, the limitations of the methodologies were also discussed.
Förderung
- King Khalid University
Zitieren
APA
Varala, R., Seema, V., Kamsali, M. M. A., Hussein, M., & Alam, M. M. (2025). K 2 S 2 O 8 (Potassium Persulfate)‐Mediated Heterocyclic Ring Formations. ChemistrySelect, 10(35). https://doi.org/10.1002/slct.202503555
Vancouver
Varala R, Seema V, Kamsali MMA, Hussein M, Alam MM. K 2 S 2 O 8 (Potassium Persulfate)‐Mediated Heterocyclic Ring Formations. ChemistrySelect. 2025;10(35). doi:10.1002/slct.202503555
BibTeX
@article{Varala2025,
author = {Varala, Ravi and Seema, Vittal and Kamsali, Murali Mohan Achari and Hussein, Mohamed and Alam, Mohammed Mujahid},
title = {K 2 S 2 O 8 (Potassium Persulfate)‐Mediated Heterocyclic Ring Formations},
journal = {ChemistrySelect},
year = {2025},
volume = {10},
number = {35},
doi = {10.1002/slct.202503555}
}
EUVIMED